World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
21741
World Ranking
17190
National Ranking
897

Overview

Michael Bamberg is affiliated with the University of Tübingen in Germany and contributes to the field of Medicine with a focus on several specialized subfields. Their research spans Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Radiation, Epidemiology, and Critical Care and Intensive Care Medicine.

The scientist's work covers key topics including:

  • Lung Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Advanced Radiotherapy Techniques
  • Electrolyte and hormonal disorders
  • Burn Injury Management and Outcomes
  • Thermal Regulation in Medicine

Michael Bamberg has coauthored publications with several frequent collaborators, including Ursula Nestle, Marco Tosch, Thomas Hehr, S. Eschmann, and G. Höll. This network of coauthors reflects a multidisciplinary approach spanning imaging, oncology, and critical care.

Their recent publications demonstrate a focus on imaging and the clinical management of severe conditions. Notable papers include:

  • "Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial" (2020), published in The Lancet Oncology
  • "Severe Burn Injuries - The Day the Sodium Starts Rising" (2024), published in In Vivo
  • "The Delayed Cortisol Peak Effect After Severe Burn Injury: A Prospective Observational Study" (2025), published in In Vivo

These publications highlight Bamberg's engagement with both oncology and critical care medicine, emphasizing advanced imaging modalities and hormonal or electrolyte dynamics in burn injury contexts.

Their findings are often published in journals such as In Vivo and The Lancet Oncology, which appear frequently in their publication record. This emphasizes the clinical and translational nature of their research.

Best Publications

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

    Rolf D. Kortmann;Joachim Kühl;Beate Timmermann;Uwe Mittler

  • Cellular basis of radiation-induced fibrosis

    H.Peter Rodemann;Michael Bamberg

  • Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

    Wilhelm Küker;Thomas Nägele;Agnieska Korfel;Stefan Heckl

  • Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial

    Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann

  • Radiation induced CNS toxicity – molecular and cellular mechanisms

    C Belka;W Budach;R D Kortmann;M Bamberg

  • Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89.

    Michael Bamberg;Rolf-D. Kortmann;Gabriele Calaminus;Gerd Becker

  • Radiotherapy for Stages IIA/B Testicular Seminoma: Final Report of a Prospective Multicenter Clinical Trial

    Johannes Classen;Heinz Schmidberger;Christoph Meisner;Rainer Souchon

  • NOA‐03 trial of high‐dose methotrexate in primary central nervous system lymphoma: Final report

    Ulrich Herrlinger;Wilhelm Küker;Martin Uhl;Hans-Peter Blaicher

  • Intracranial germ cell tumors: a comprehensive update of the European data.

    G. Calaminus;M. Bamberg;M. C. Baranzelli;Y. Benoit

  • Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91.

    Beate Timmermann;Rolf-Dieter Kortmann;Joachim Kühl;Christoph Meisner

  • Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids

    Albrecht Lepple-Wienhues;Claus Belka;Tilmann Laun;Andreas Jekle

  • German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.

    Ulrich Herrlinger;Martin Schabet;Wolfram Brugger;Rolf-Dieter Kortmann

  • Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

    Wolfgang Wick;Patrick Roth;Christian Hartmann;Christian Hartmann;Peter Hau

  • One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma.

    Wolfgang Wick;J. P. Steinbach;W. M. Küker;J. Dichgans

  • Molecular and cellular basis of radiation fibrosis

    A. Burger;H. Löffler;M. Bamberg;H. P. Rodemann

  • Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.

    Wolfgang Wick;Patrick Roth;Benedikt Wiestler;Christian Hartmann

Frequent Co-Authors

Claus Belka
Claus Belka Ludwig-Maximilians-Universität München
Michael Weller
Michael Weller University of Zurich
Lothar Kanz
Lothar Kanz University of Tübingen
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Diethelm Wallwiener
Diethelm Wallwiener University of Tübingen
Klaus Schulze-Osthoff
Klaus Schulze-Osthoff University of Tübingen
Johannes Dichgans
Johannes Dichgans University of Tübingen
Verena Jendrossek
Verena Jendrossek University of Duisburg-Essen
Hans-Joachim Schmoll
Hans-Joachim Schmoll Martin Luther University Halle-Wittenberg
Guido Reifenberger
Guido Reifenberger Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine but want flexible study options, there are a range of online healthcare degrees to explore. For those seeking a hands-on patient care role, lpn accelerated program options offer a fast-track pathway to licensed practical nursing, letting you enter the field more quickly.

Advanced nursing roles are also accessible online. The demand for mental health expertise means online psych np programs are becoming more popular; these prepare students for high-impact careers as psychiatric nurse practitioners.

If you're interested in the business side of healthcare, a online healthcare administration degree covers essential skills in management and leadership. For those seeking advanced responsibilities without incurring high costs, the cheapest mha programs online provide a budget-friendly route to a master's in healthcare administration.

These online pathways offer flexibility, affordability, and the chance to specialize—making them attractive alternatives or supplements to traditional medical education in the USA.

Best Scientists Citing Michael Bamberg

Trending Scientists

Recently Published Articles